Consumer Health: Quarterly Statement Q2 2021

June 2021

Expectations for the global consumer health industry have improved slightly for Q2 2021. Improved macroeconomic forecasts due to widening vaccination rates in markets such as the US will benefit consumer health, especially as consumers emerge from the home seclusion and social distancing prevalent in 2020. The second wave of COVID-19 cases in India, however, reinforces the continued disruption in some markets, where industry sales will likely be suppressed throughout the year.

USD 1,325
Request More Information
Key Findings
Q2 global forecast a slight improvement on Q1
Emerging economies seeing slight downward revisions in Q1 review
Second wave of COVID-19 in India lowers near-term expectations
COVID-19 outbreak in India creates uncertainty in near-term forecasting
Q1 financial results reinforce the hole constraining near-term growth
2021 acquisitions point to near-term opportunities for growth
Greater industry consensus on near-term growth than a year prior
Predicting consumer behaviours and the impact on consumer health
Factors to watch in 2021
Global baseline outlook: Faster recovery expected
Uncertainty continues to decline but remains significant
Real GDP annual growth forecasts and revisions from last quarter, AE
Real GDP annual growth forecasts and revisions from last quarter, EMDE
About Consumer Health quarterly forecast updates
Euromonitor International and COVID-19: Forecasts and analysis
Data and reporting timeline for Consumer Health

Consumer Health

It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing

See All of Our Definitions


If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!